Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Start your free trial now

Instant access. No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Archives

You are currently viewing the 2001 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Details for NDA: 021153

« Back to Dashboard
NDA 021153 describes NEXIUM, which is a drug marketed by Astrazeneca Pharms and Astrazeneca Lp and is included in one NDA. It is available from eleven suppliers. There are thirteen patents protecting this drug and three Paragraph IV challenges. Additional details are available on the NEXIUM profile page.

The generic ingredient in NEXIUM is esomeprazole magnesium. There are fifty-three drug master file entries for this compound. Twelve suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the esomeprazole magnesium profile page.

Summary for NDA: 021153

esomeprazole magnesium
Suppliers: see list11
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 021153


Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:Capsule, Delayed Rel Pellets; OralStrengthEQ 20MG BASE
Approval Date:FEB 20, 2001TE:RLD:Yes
Patent:4,508,905Patent Expiration:FEB 20,2001Product Flag?Substance Flag?Delist Request?
Patent:6,147,103Patent Expiration:OCT 09,2018Product Flag?Substance Flag?Delist Request?
Patent:6,166,213Patent Expiration:OCT 09,2018Product Flag?Substance Flag?Delist Request?

Complete Access Available with Subscription
« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn